ID: ALA270022

Max Phase: Preclinical

Molecular Formula: C26H26O3

Molecular Weight: 386.49

Molecule Type: Small molecule

Associated Items:

Representations

Synonyms (1): 2,6-Bis(4-(Allyloxy)Benzylidene)Cyclohexanone
Synonyms from Alternative Forms(1):

    Canonical SMILES:  C=CCOc1ccc(/C=C2\CCC/C(=C\c3ccc(OCC=C)cc3)C2=O)cc1

    Standard InChI:  InChI=1S/C26H26O3/c1-3-16-28-24-12-8-20(9-13-24)18-22-6-5-7-23(26(22)27)19-21-10-14-25(15-11-21)29-17-4-2/h3-4,8-15,18-19H,1-2,5-7,16-17H2/b22-18+,23-19+

    Standard InChI Key:  WPEPTQIPLDEXCZ-DPIBHUQISA-N

    Associated Targets(Human)

    HL-60 67320 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    11-beta-hydroxysteroid dehydrogenase 1 5910 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    11-beta-hydroxysteroid dehydrogenase 2 1168 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Associated Targets(non-human)

    J774.A1 2436 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    11-beta-hydroxysteroid dehydrogenase 2 82 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    11-beta-hydroxysteroid dehydrogenase 1 202 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Molecule Features

    Natural Product: NoOral: NoChemical Probe: NoParenteral: No
    Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
    Chirality: NoAvailability: NoProdrug: No

    Drug Indications

    MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

    Mechanisms of Action

    Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

    Properties

    Molecular Weight: 386.49Molecular Weight (Monoisotopic): 386.1882AlogP: 6.04#Rotatable Bonds: 8
    Polar Surface Area: 35.53Molecular Species: NEUTRALHBA: 3HBD: 0
    #RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
    CX Acidic pKa: CX Basic pKa: CX LogP: 6.74CX LogD: 6.74
    Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.41Np Likeness Score: -0.26

    References

    1. Liang G, Li X, Chen L, Yang S, Wu X, Studer E, Gurley E, Hylemon PB, Ye F, Li Y, Zhou H..  (2008)  Synthesis and anti-inflammatory activities of mono-carbonyl analogues of curcumin.,  18  (4): [PMID:18234497] [10.1016/j.bmcl.2007.12.068]
    2. Liang G, Shao L, Wang Y, Zhao C, Chu Y, Xiao J, Zhao Y, Li X, Yang S..  (2009)  Exploration and synthesis of curcumin analogues with improved structural stability both in vitro and in vivo as cytotoxic agents.,  17  (6): [PMID:19243951] [10.1016/j.bmc.2008.10.044]
    3. Lin H, Hu GX, Guo J, Ge Y, Liang G, Lian QQ, Chu Y, Yuan X, Huang P, Ge RS..  (2013)  Mono-carbonyl curcumin analogues as 11β-hydroxysteroid dehydrogenase 1 inhibitors.,  23  (15): [PMID:23800686] [10.1016/j.bmcl.2013.05.080]

    Source